Mission, Vision & Goals

MRP Role Statement

Prevent kidney disease, promote kidney health and provide kidney health services to Manitobans.


The Mission of the Manitoba Renal Program is to:

  • to provide early identification and treatment of people at high risk for renal disease
  • to provide ongoing care to these people and their families to maintain or enhance quality of life, including end of life management and to assist in adaptation to chronic illness as close to their home communities as possible
  • to achieve our mission in a fiscally responsible manner through the provision of education, health promotion, disease prevention, clinical expertise, technical excellence, research and respectful and collaborative interdisciplinary practice


In 1998, when the Manitoba Renal Program (MRP) was established, we developed a universal vision for the program. This vision guides our health Care professionals today.

MRP vision is to:

  • Provide a uniform standard of high quality care
  • Provide equitable access to all therapies and resources
  • Develop Renal Health Promotion and Disease Prevention Outreach
  • Develop Provincial Renal Disease Database
  • Create Patient/Aboriginal Advocacy Committee
  • Develop Research and Development Committee
  • Plan expanded dialysis service to mirror growth


The MRP develops and provides two broad elements along the continuum of care of renal disease:

  • Kidney Replacement Therapy  used to improve or maintain a high quality of life for individuals with ESRD through the provision of dialysis for both acute and chronic kidney disease.
  • Kidney Health Outreach responsible for renal health promotion, disease prevention and management through education and non dialysis clinical care.


The objective of the Strategic Plan is to formulate an integrated, patient-centred and efficient model of service delivery that meets the increasing demand for adult kidney health services in Manitoba.

Key considerations in this Plan include:

  • Chronic kidney disease (CKD) is a global public health problem that is associated with poor health outcomes and decreased longevity.
  • CKD consumes a disproportionate amount of health-care resources related to the cost of dialysis and to the cost of its cardiovascular complications including stroke, heart attacks, heart failure and limb amputation.
  • The number of people in Manitoba with CKD is projected to exponentially increase into the future.
  • Manitoba has the highest incident rate (222.6 per million population) and the second highest prevalent rate of End Stage Kidney Disease (ESKD) (1559.6 per million population) in Canada.
  • Manitoba’s First Nations population is over represented in the Manitoba ESKD population. It comprises 16% of the general population but approximately 35% of the provincial dialysis population. Canadian Aboriginal people are 3 times more likely to require kidney replacement therapy.
  • Diabetes is the predominant cause of CKD in Manitoba’s First Nations population. Manitoba has the highest prevalent rate of ESKD caused by diabetes at 38.8% compared to 27.1% nationally.
  • Manitoba’s First Nations population is approximately 1.6 times more likely to have diabetes compared to the general population of in Manitoba.
  • The Manitoba First Nations population is anticipated to increase from 16 to 21% of the provincial population by 2031.
  • The prevalence of CKD and associated chronic conditions within Manitoba’s First Nations, Metis, rural and northern populations pose unique challenges in the provision of CKD care delivery.
  • While there is no cure for CKD, it can be effectively treated. Its progression to ESKD requiring dialysis can be halted or delayed with treatment.
  • The majority of people with CKD can be managed in the community by primary care providers.
  • CKD in its early stages is often symptom free but is easy to diagnose with targeted screening of at-risk individuals.
  • Where appropriate, transplantation is the preferred and most cost effective treatment for ESKD. The growth in incident and prevalent of ESKD is primarily seen in older individuals who are often not eligible for transplantation due to multiple comorbidities.

Key strategic priorities for Renal Services in Manitoba for 2014-2017:

  1. Optimize CKD prevention through improved surveillance, screening and risk based intervention
  2. Optimize treatment options for ESKD and improve utilization of lower cost effective modalities
  3. Strengthen CKD care through research and innovation
  4. Enhance patient involvement in management of care